Blackburn, Natalie A.
Joniak-Grant, Elizabeth
Nocera, Maryalice
Dorris, Samantha Wooten
Dasgupta, Nabarun
Chelminski, Paul R.
Carey, Timothy S.
Wu, Li-Tzy
Edwards, David A.
Marshall, Stephen W.
Ranapurwala, Shabbar I.
Article History
Received: 25 March 2021
Accepted: 26 October 2021
First Online: 3 November 2021
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki. All study materials were reviewed and approved by the Institutional Review Board (IRB) at the University of North Carolina, Chapel Hill (study# 18–2437). The study was deemed minimal risk. All participants provided written informed consent before participating in the study.
: Not applicable.
: ND is a scientific methods advisor on opioid topics to the RADARS System of Denver Health and Hospitals Authority and the US Food and Drug Administration. Neither organization had knowledge of or involvement in the work presented herein. All other authors declare that they have no competing interests.